Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Market Analysis and Insights: Global Anti - Neoplastic Agents Market
The global Anti - Neoplastic Agents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Anti - Neoplastic Agents Scope and Segment
The global Anti - Neoplastic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti - Neoplastic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy(Biologic Therapy)
Others
By the end users/application, this report covers the following segments
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Competitive Landscape:
The report provides a list of all the key players in the Anti - Neoplastic Agents market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anti - Neoplastic Agents key manufacturers in this market include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market Analysis and Insights: Global Anti - Neoplastic Agents Market
The global Anti - Neoplastic Agents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Anti - Neoplastic Agents Scope and Segment
The global Anti - Neoplastic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti - Neoplastic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy(Biologic Therapy)
Others
By the end users/application, this report covers the following segments
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Competitive Landscape:
The report provides a list of all the key players in the Anti - Neoplastic Agents market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Anti - Neoplastic Agents key manufacturers in this market include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
1 Anti - Neoplastic Agents Market Overview
1.1 Anti - Neoplastic Agents Product Overview
1.2 Anti - Neoplastic Agents Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy(Biologic Therapy)
1.2.5 Others
1.3 Global Anti - Neoplastic Agents Market Size by Type
1.3.1 Global Anti - Neoplastic Agents Market Size Overview by Type (2016-2027)
1.3.2 Global Anti - Neoplastic Agents Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anti - Neoplastic Agents Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anti - Neoplastic Agents Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anti - Neoplastic Agents Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
2 Global Anti - Neoplastic Agents Market Competition by Company
2.1 Global Top Players by Anti - Neoplastic Agents Sales (2016-2021)
2.2 Global Top Players by Anti - Neoplastic Agents Revenue (2016-2021)
2.3 Global Top Players Anti - Neoplastic Agents Price (2016-2021)
2.4 Global Top Manufacturers Anti - Neoplastic Agents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti - Neoplastic Agents Market Competitive Situation and Trends
2.5.1 Anti - Neoplastic Agents Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti - Neoplastic Agents Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti - Neoplastic Agents as of 2020)
2.7 Date of Key Manufacturers Enter into Anti - Neoplastic Agents Market
2.8 Key Manufacturers Anti - Neoplastic Agents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti - Neoplastic Agents Status and Outlook by Region
3.1 Global Anti - Neoplastic Agents Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anti - Neoplastic Agents Historic Market Size by Region
3.2.1 Global Anti - Neoplastic Agents Sales in Volume by Region (2016-2021)
3.2.2 Global Anti - Neoplastic Agents Sales in Value by Region (2016-2021)
3.2.3 Global Anti - Neoplastic Agents Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anti - Neoplastic Agents Forecasted Market Size by Region
3.3.1 Global Anti - Neoplastic Agents Sales in Volume by Region (2022-2027)
3.3.2 Global Anti - Neoplastic Agents Sales in Value by Region (2022-2027)
3.3.3 Global Anti - Neoplastic Agents Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anti - Neoplastic Agents by Application
4.1 Anti - Neoplastic Agents Market Segment by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory/Lung Cancer
4.1.6 Other Cancers
4.2 Global Anti - Neoplastic Agents Market Size by Application
4.2.1 Global Anti - Neoplastic Agents Market Size Overview by Application (2016-2027)
4.2.2 Global Anti - Neoplastic Agents Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anti - Neoplastic Agents Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anti - Neoplastic Agents Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anti - Neoplastic Agents Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
5 North America Anti - Neoplastic Agents by Country
5.1 North America Anti - Neoplastic Agents Historic Market Size by Country
5.1.1 North America Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
5.1.2 North America Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
5.2 North America Anti - Neoplastic Agents Forecasted Market Size by Country
5.2.1 North America Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
5.2.2 North America Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
6 Europe Anti - Neoplastic Agents by Country
6.1 Europe Anti - Neoplastic Agents Historic Market Size by Country
6.1.1 Europe Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
6.1.2 Europe Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
6.2 Europe Anti - Neoplastic Agents Forecasted Market Size by Country
6.2.1 Europe Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
6.2.2 Europe Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
7 Asia-Pacific Anti - Neoplastic Agents by Region
7.1 Asia-Pacific Anti - Neoplastic Agents Historic Market Size by Region
7.1.1 Asia-Pacific Anti - Neoplastic Agents Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anti - Neoplastic Agents Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anti - Neoplastic Agents Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti - Neoplastic Agents Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anti - Neoplastic Agents Sales in Value by Region (2022-2027)
8 Latin America Anti - Neoplastic Agents by Country
8.1 Latin America Anti - Neoplastic Agents Historic Market Size by Country
8.1.1 Latin America Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
8.2 Latin America Anti - Neoplastic Agents Forecasted Market Size by Country
8.2.1 Latin America Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
9 Middle East and Africa Anti - Neoplastic Agents by Country
9.1 Middle East and Africa Anti - Neoplastic Agents Historic Market Size by Country
9.1.1 Middle East and Africa Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anti - Neoplastic Agents Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anti - Neoplastic Agents Business
10.1 Roche
10.1.1 Roche Corporation Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Roche Anti - Neoplastic Agents Products Offered
10.1.5 Roche Recent Development
10.2 Novartis
10.2.1 Novartis Corporation Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Roche Anti - Neoplastic Agents Products Offered
10.2.5 Novartis Recent Development
10.3 Celgene
10.3.1 Celgene Corporation Information
10.3.2 Celgene Introduction and Business Overview
10.3.3 Celgene Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Celgene Anti - Neoplastic Agents Products Offered
10.3.5 Celgene Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Corporation Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bristol-Myers Squibb Anti - Neoplastic Agents Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Amgen
10.5.1 Amgen Corporation Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Amgen Anti - Neoplastic Agents Products Offered
10.5.5 Amgen Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Corporation Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson & Johnson Anti - Neoplastic Agents Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Pfizer
10.7.1 Pfizer Corporation Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Pfizer Anti - Neoplastic Agents Products Offered
10.7.5 Pfizer Recent Development
10.8 Takeda
10.8.1 Takeda Corporation Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Takeda Anti - Neoplastic Agents Products Offered
10.8.5 Takeda Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Corporation Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Eli Lilly Anti - Neoplastic Agents Products Offered
10.9.5 Eli Lilly Recent Development
10.10 AstraZeneca
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti - Neoplastic Agents Product Category, Application and Specification
10.10.3 AstraZeneca Anti - Neoplastic Agents Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 AstraZeneca Recent Development
10.11 Astellas
10.11.1 Astellas Corporation Information
10.11.2 Astellas Introduction and Business Overview
10.11.3 Astellas Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Astellas Anti - Neoplastic Agents Products Offered
10.11.5 Astellas Recent Development
10.12 Merck & Co.
10.12.1 Merck & Co. Corporation Information
10.12.2 Merck & Co. Introduction and Business Overview
10.12.3 Merck & Co. Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Merck & Co. Anti - Neoplastic Agents Products Offered
10.12.5 Merck & Co. Recent Development
10.13 Sanofi
10.13.1 Sanofi Corporation Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Sanofi Anti - Neoplastic Agents Products Offered
10.13.5 Sanofi Recent Development
10.14 Bayer
10.14.1 Bayer Corporation Information
10.14.2 Bayer Introduction and Business Overview
10.14.3 Bayer Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Bayer Anti - Neoplastic Agents Products Offered
10.14.5 Bayer Recent Development
10.15 Biogen Idec
10.15.1 Biogen Idec Corporation Information
10.15.2 Biogen Idec Introduction and Business Overview
10.15.3 Biogen Idec Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Biogen Idec Anti - Neoplastic Agents Products Offered
10.15.5 Biogen Idec Recent Development
10.16 Eisai
10.16.1 Eisai Corporation Information
10.16.2 Eisai Introduction and Business Overview
10.16.3 Eisai Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Eisai Anti - Neoplastic Agents Products Offered
10.16.5 Eisai Recent Development
10.17 Teva
10.17.1 Teva Corporation Information
10.17.2 Teva Introduction and Business Overview
10.17.3 Teva Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Teva Anti - Neoplastic Agents Products Offered
10.17.5 Teva Recent Development
10.18 Otsuka
10.18.1 Otsuka Corporation Information
10.18.2 Otsuka Introduction and Business Overview
10.18.3 Otsuka Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Otsuka Anti - Neoplastic Agents Products Offered
10.18.5 Otsuka Recent Development
10.19 Merck KGaA
10.19.1 Merck KGaA Corporation Information
10.19.2 Merck KGaA Introduction and Business Overview
10.19.3 Merck KGaA Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Merck KGaA Anti - Neoplastic Agents Products Offered
10.19.5 Merck KGaA Recent Development
10.20 Ipsen
10.20.1 Ipsen Corporation Information
10.20.2 Ipsen Introduction and Business Overview
10.20.3 Ipsen Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Ipsen Anti - Neoplastic Agents Products Offered
10.20.5 Ipsen Recent Development
10.21 AbbVie
10.21.1 AbbVie Corporation Information
10.21.2 AbbVie Introduction and Business Overview
10.21.3 AbbVie Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.21.4 AbbVie Anti - Neoplastic Agents Products Offered
10.21.5 AbbVie Recent Development
10.22 Gilead Sciences
10.22.1 Gilead Sciences Corporation Information
10.22.2 Gilead Sciences Introduction and Business Overview
10.22.3 Gilead Sciences Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Gilead Sciences Anti - Neoplastic Agents Products Offered
10.22.5 Gilead Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti - Neoplastic Agents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti - Neoplastic Agents Industrial Chain Analysis
11.4 Anti - Neoplastic Agents Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti - Neoplastic Agents Distributors
12.3 Anti - Neoplastic Agents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Anti - Neoplastic Agents Product Overview
1.2 Anti - Neoplastic Agents Market Segment by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy(Biologic Therapy)
1.2.5 Others
1.3 Global Anti - Neoplastic Agents Market Size by Type
1.3.1 Global Anti - Neoplastic Agents Market Size Overview by Type (2016-2027)
1.3.2 Global Anti - Neoplastic Agents Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anti - Neoplastic Agents Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anti - Neoplastic Agents Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anti - Neoplastic Agents Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anti - Neoplastic Agents Sales Breakdown by Type (2016-2021)
2 Global Anti - Neoplastic Agents Market Competition by Company
2.1 Global Top Players by Anti - Neoplastic Agents Sales (2016-2021)
2.2 Global Top Players by Anti - Neoplastic Agents Revenue (2016-2021)
2.3 Global Top Players Anti - Neoplastic Agents Price (2016-2021)
2.4 Global Top Manufacturers Anti - Neoplastic Agents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti - Neoplastic Agents Market Competitive Situation and Trends
2.5.1 Anti - Neoplastic Agents Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti - Neoplastic Agents Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti - Neoplastic Agents as of 2020)
2.7 Date of Key Manufacturers Enter into Anti - Neoplastic Agents Market
2.8 Key Manufacturers Anti - Neoplastic Agents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti - Neoplastic Agents Status and Outlook by Region
3.1 Global Anti - Neoplastic Agents Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anti - Neoplastic Agents Historic Market Size by Region
3.2.1 Global Anti - Neoplastic Agents Sales in Volume by Region (2016-2021)
3.2.2 Global Anti - Neoplastic Agents Sales in Value by Region (2016-2021)
3.2.3 Global Anti - Neoplastic Agents Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anti - Neoplastic Agents Forecasted Market Size by Region
3.3.1 Global Anti - Neoplastic Agents Sales in Volume by Region (2022-2027)
3.3.2 Global Anti - Neoplastic Agents Sales in Value by Region (2022-2027)
3.3.3 Global Anti - Neoplastic Agents Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anti - Neoplastic Agents by Application
4.1 Anti - Neoplastic Agents Market Segment by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory/Lung Cancer
4.1.6 Other Cancers
4.2 Global Anti - Neoplastic Agents Market Size by Application
4.2.1 Global Anti - Neoplastic Agents Market Size Overview by Application (2016-2027)
4.2.2 Global Anti - Neoplastic Agents Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anti - Neoplastic Agents Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anti - Neoplastic Agents Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anti - Neoplastic Agents Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anti - Neoplastic Agents Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anti - Neoplastic Agents Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anti - Neoplastic Agents Sales Breakdown by Application (2016-2021)
5 North America Anti - Neoplastic Agents by Country
5.1 North America Anti - Neoplastic Agents Historic Market Size by Country
5.1.1 North America Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
5.1.2 North America Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
5.2 North America Anti - Neoplastic Agents Forecasted Market Size by Country
5.2.1 North America Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
5.2.2 North America Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
6 Europe Anti - Neoplastic Agents by Country
6.1 Europe Anti - Neoplastic Agents Historic Market Size by Country
6.1.1 Europe Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
6.1.2 Europe Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
6.2 Europe Anti - Neoplastic Agents Forecasted Market Size by Country
6.2.1 Europe Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
6.2.2 Europe Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
7 Asia-Pacific Anti - Neoplastic Agents by Region
7.1 Asia-Pacific Anti - Neoplastic Agents Historic Market Size by Region
7.1.1 Asia-Pacific Anti - Neoplastic Agents Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anti - Neoplastic Agents Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anti - Neoplastic Agents Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti - Neoplastic Agents Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anti - Neoplastic Agents Sales in Value by Region (2022-2027)
8 Latin America Anti - Neoplastic Agents by Country
8.1 Latin America Anti - Neoplastic Agents Historic Market Size by Country
8.1.1 Latin America Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
8.2 Latin America Anti - Neoplastic Agents Forecasted Market Size by Country
8.2.1 Latin America Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
9 Middle East and Africa Anti - Neoplastic Agents by Country
9.1 Middle East and Africa Anti - Neoplastic Agents Historic Market Size by Country
9.1.1 Middle East and Africa Anti - Neoplastic Agents Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anti - Neoplastic Agents Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anti - Neoplastic Agents Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti - Neoplastic Agents Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anti - Neoplastic Agents Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anti - Neoplastic Agents Business
10.1 Roche
10.1.1 Roche Corporation Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Roche Anti - Neoplastic Agents Products Offered
10.1.5 Roche Recent Development
10.2 Novartis
10.2.1 Novartis Corporation Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Roche Anti - Neoplastic Agents Products Offered
10.2.5 Novartis Recent Development
10.3 Celgene
10.3.1 Celgene Corporation Information
10.3.2 Celgene Introduction and Business Overview
10.3.3 Celgene Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Celgene Anti - Neoplastic Agents Products Offered
10.3.5 Celgene Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Corporation Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Bristol-Myers Squibb Anti - Neoplastic Agents Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Amgen
10.5.1 Amgen Corporation Information
10.5.2 Amgen Introduction and Business Overview
10.5.3 Amgen Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Amgen Anti - Neoplastic Agents Products Offered
10.5.5 Amgen Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Corporation Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Johnson & Johnson Anti - Neoplastic Agents Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Pfizer
10.7.1 Pfizer Corporation Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Pfizer Anti - Neoplastic Agents Products Offered
10.7.5 Pfizer Recent Development
10.8 Takeda
10.8.1 Takeda Corporation Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Takeda Anti - Neoplastic Agents Products Offered
10.8.5 Takeda Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Corporation Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Eli Lilly Anti - Neoplastic Agents Products Offered
10.9.5 Eli Lilly Recent Development
10.10 AstraZeneca
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti - Neoplastic Agents Product Category, Application and Specification
10.10.3 AstraZeneca Anti - Neoplastic Agents Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 AstraZeneca Recent Development
10.11 Astellas
10.11.1 Astellas Corporation Information
10.11.2 Astellas Introduction and Business Overview
10.11.3 Astellas Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Astellas Anti - Neoplastic Agents Products Offered
10.11.5 Astellas Recent Development
10.12 Merck & Co.
10.12.1 Merck & Co. Corporation Information
10.12.2 Merck & Co. Introduction and Business Overview
10.12.3 Merck & Co. Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Merck & Co. Anti - Neoplastic Agents Products Offered
10.12.5 Merck & Co. Recent Development
10.13 Sanofi
10.13.1 Sanofi Corporation Information
10.13.2 Sanofi Introduction and Business Overview
10.13.3 Sanofi Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Sanofi Anti - Neoplastic Agents Products Offered
10.13.5 Sanofi Recent Development
10.14 Bayer
10.14.1 Bayer Corporation Information
10.14.2 Bayer Introduction and Business Overview
10.14.3 Bayer Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Bayer Anti - Neoplastic Agents Products Offered
10.14.5 Bayer Recent Development
10.15 Biogen Idec
10.15.1 Biogen Idec Corporation Information
10.15.2 Biogen Idec Introduction and Business Overview
10.15.3 Biogen Idec Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Biogen Idec Anti - Neoplastic Agents Products Offered
10.15.5 Biogen Idec Recent Development
10.16 Eisai
10.16.1 Eisai Corporation Information
10.16.2 Eisai Introduction and Business Overview
10.16.3 Eisai Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Eisai Anti - Neoplastic Agents Products Offered
10.16.5 Eisai Recent Development
10.17 Teva
10.17.1 Teva Corporation Information
10.17.2 Teva Introduction and Business Overview
10.17.3 Teva Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.17.4 Teva Anti - Neoplastic Agents Products Offered
10.17.5 Teva Recent Development
10.18 Otsuka
10.18.1 Otsuka Corporation Information
10.18.2 Otsuka Introduction and Business Overview
10.18.3 Otsuka Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.18.4 Otsuka Anti - Neoplastic Agents Products Offered
10.18.5 Otsuka Recent Development
10.19 Merck KGaA
10.19.1 Merck KGaA Corporation Information
10.19.2 Merck KGaA Introduction and Business Overview
10.19.3 Merck KGaA Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.19.4 Merck KGaA Anti - Neoplastic Agents Products Offered
10.19.5 Merck KGaA Recent Development
10.20 Ipsen
10.20.1 Ipsen Corporation Information
10.20.2 Ipsen Introduction and Business Overview
10.20.3 Ipsen Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.20.4 Ipsen Anti - Neoplastic Agents Products Offered
10.20.5 Ipsen Recent Development
10.21 AbbVie
10.21.1 AbbVie Corporation Information
10.21.2 AbbVie Introduction and Business Overview
10.21.3 AbbVie Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.21.4 AbbVie Anti - Neoplastic Agents Products Offered
10.21.5 AbbVie Recent Development
10.22 Gilead Sciences
10.22.1 Gilead Sciences Corporation Information
10.22.2 Gilead Sciences Introduction and Business Overview
10.22.3 Gilead Sciences Anti - Neoplastic Agents Sales, Revenue and Gross Margin (2016-2021)
10.22.4 Gilead Sciences Anti - Neoplastic Agents Products Offered
10.22.5 Gilead Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti - Neoplastic Agents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti - Neoplastic Agents Industrial Chain Analysis
11.4 Anti - Neoplastic Agents Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti - Neoplastic Agents Distributors
12.3 Anti - Neoplastic Agents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
